Hobbs Group Advisors, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 2012280
COLUMBIA, SC
Position in REGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$505,067
+$298,000 QoQ
Shares Held
810
+202.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
#799
of 1,322 holders
Holding Since
Dec 2023
8 quarters on record
Voting authority
Sole 7%
Shared 0%
None 93%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Hobbs Group Advisors, LLC holds $526,554 across 2 Biotechnology names. REGN ranks #1 (95.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
810 | $505,067 | |
| 2 | ATYR |
aTYR PHARMA INC
|
35,992 | $21,487 |
All Filings in REGN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $505,067 | 810 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $207,067 | 268 | Shares | Sole | 2026-05-20 | |
| 2025-12-31 | $243,139 | 315 | Shares | Sole | 2026-01-28 | |
| 2025-06-30 | $203,175 | 387 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $591,102 | 932 | Shares | Sole | 2025-05-14 | |
| 2024-09-30 | $271,219 | 258 | Shares | Sole | 2024-11-18 | |
| 2024-06-30 | $271,165 | 258 | Shares | Sole | 2024-07-22 | |
| 2023-12-31 | $263,487 | 300 | Shares | Sole | 2024-02-16 | |
| No filing history on record for this holder in this stock. | ||||||